Generex Biotechnology Corporation

Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the first tranche acquisition of certain operating assets from Veneto Holdings, L.L.C. ("Veneto") and certain of its affiliated entities (collectively, the "Veneto Group").

First Tranche Acquisition

Member
Brooks Houghton

Sector
Healthcare / Pharmaceuticals / MedTech / Lifescience

Date completed
08.10.2018

Target company
Veneto Holdings, LLC

Target country
-

Acquirer company
Generex Biotechnology Corporation

Acquirer country
-

Get in touch and let's talk about how we could help your business.

Get Started